These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38328920)

  • 21. Toxicity of metal-based nanoparticles: Challenges in the nano era.
    Zhang N; Xiong G; Liu Z
    Front Bioeng Biotechnol; 2022; 10():1001572. PubMed ID: 36619393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotoxicity: the toxicity research progress of metal and metal-containing nanoparticles.
    Ding L; Liu Z; Aggrey MO; Li C; Chen J; Tong L
    Mini Rev Med Chem; 2015; 15(7):529-42. PubMed ID: 25934980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upconverting nanoparticles: assessing the toxicity.
    Gnach A; Lipinski T; Bednarkiewicz A; Rybka J; Capobianco JA
    Chem Soc Rev; 2015 Mar; 44(6):1561-84. PubMed ID: 25176037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.
    Manzari-Tavakoli A; Babajani A; Tavakoli MM; Safaeinejad F; Jafari A
    Cancer Med; 2024 Mar; 13(5):e7010. PubMed ID: 38491817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanoparticles for pulmonary drug delivery.
    García-Fernández A; Sancenón F; Martínez-Máñez R
    Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticles Toxicity in Fish Models.
    Cazenave J; Ale A; Bacchetta C; Rossi AS
    Curr Pharm Des; 2019; 25(37):3927-3942. PubMed ID: 31512995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of the Beneficial Role of Antioxidants in the Treatment of Nanoparticle-Induced Toxicities.
    Mihailovic V; Katanic Stankovic JS; Selakovic D; Rosic G
    Oxid Med Cell Longev; 2021; 2021():7244677. PubMed ID: 34820054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles: a review of particle toxicology following inhalation exposure.
    Bakand S; Hayes A; Dechsakulthorn F
    Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicological status of nanoparticles: What we know and what we don't know.
    Missaoui WN; Arnold RD; Cummings BS
    Chem Biol Interact; 2018 Nov; 295():1-12. PubMed ID: 30048623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabricated nanoparticles: current status and potential phytotoxic threats.
    Yadav T; Mungray AA; Mungray AK
    Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology as a tool to overcome macromolecules delivery issues.
    Tundisi LL; Ataide JA; Costa JSR; Coêlho DF; Liszbinski RB; Lopes AM; Oliveira-Nascimento L; de Jesus MB; Jozala AF; Ehrhardt C; Mazzola PG
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113043. PubMed ID: 36455361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotoxicity assessment in plants: an updated overview.
    Zafar H; Javed R; Zia M
    Environ Sci Pollut Res Int; 2023 Sep; 30(41):93323-93344. PubMed ID: 37544947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
    Mohammed L; Ragab D; Gomaa H
    Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of metallic, metallic oxide, and organic nanoparticles on plant physiology.
    Ahmad A; Hashmi SS; Palma JM; Corpas FJ
    Chemosphere; 2022 Mar; 290():133329. PubMed ID: 34922969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic approach to nanotoxicity.
    Matysiak M; Kapka-Skrzypczak L; Brzóska K; Gutleb AC; Kruszewski M
    J Proteomics; 2016 Mar; 137():35-44. PubMed ID: 26506535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zebrafish as a Model to Evaluate Nanoparticle Toxicity.
    Haque E; Ward AC
    Nanomaterials (Basel); 2018 Jul; 8(7):. PubMed ID: 30041434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics techniques for nanotoxicity investigations.
    Lv M; Huang W; Chen Z; Jiang H; Chen J; Tian Y; Zhang Z; Xu F
    Bioanalysis; 2015; 7(12):1527-44. PubMed ID: 26168257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Situ Detection of Nanotoxicity in Living Cells Based on Multiple miRNAs Probed by a Peptide Functionalized Nanoprobe.
    Han D; Xu C; Ren XH; Peng Y; Xu B; Song JL; Chen J; Cheng SX
    Anal Chem; 2022 Feb; 94(5):2399-2407. PubMed ID: 35099175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical aspects of silver nanoparticles.
    Mathur P; Jha S; Ramteke S; Jain NK
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):115-126. PubMed ID: 29231755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.